Loading organizations...
TAMCAP LLC is a privately held family office based in San Francisco, specializing in bespoke investment management. The firm strategically allocates capital across diverse sectors, notably emphasizing growth opportunities within therapeutic devices and drug delivery companies. Their core function involves identifying and backing ventures with strong potential for innovation and market impact.
The firm is spearheaded by CEO Erik Landsness, an experienced professional with over two decades in finance and investment management. While specific founding details are privately held, TAMCAP LLC was established to offer sophisticated investors a dedicated platform for tailored capital deployment. This reflects an understanding of the demand for specialized, long-term stewardship in private markets.
TAMCAP LLC serves high-net-worth individuals and families, acting as their strategic investment partner. The firm’s long-term vision focuses on cultivating enduring value through rigorous due diligence and active portfolio management. They aim to support transformative advancements in key industries, striving to achieve sustainable returns and contribute to impactful solutions.
TAMCAP has 1 tracked investment across 1 company. The latest tracked deal is $8.0M Series A in Qool Therapeutics in November 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 28, 2017 | Qool Therapeutics | $8.0M Series A | — | BioPacific Investors, BrilliMedical International, FundRx, Western Technology Investment, Zhongji Holdings |